Guardant Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
Guardant Health, Inc. filed this Current Report on Form 8-K on January 13, 2025. The filing announces preliminary unaudited financial information for the quarter and full year ended December 31, 2024. The company is incorporated in Delaware and trades on The Nasdaq Global Select Market under the symbol GH.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus prior periods. It serves as a notification that preliminary results for the 2024 fiscal year have been announced.
Guidance, Outlook, and Management Commentary
- Conference Presentation: The Company will present at the 2025 J.P. Morgan Healthcare Conference on January 13, 2025.
- Disclosure: The presentation materials will be posted on the Company's website under the "Investors" tab on the "Events & Presentations" page.
- Legal Status: The information in this report and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 13, 2025) for specific revenue, net loss, and cash position figures.
- Access the 2025 J.P. Morgan Healthcare Conference presentation on the Guardant Health investor relations website for management commentary and outlook.
- Verify the unaudited nature of the preliminary financial data before making investment decisions.